Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Schrag

Showing results (51-60 of 383) with videos related to

Pageof 39
Sort By:
Journal of the American Statistical Association|March 18, 2017
Hierarchical models for semi-competing risks data with application to quality of end-of-life care for pancreatic cancerKyu Ha Lee, Francesca Dominici, Deborah Schrag, et al.
Journal of the National Cancer Institute|July 7, 2016
Beyond Composite Endpoints Analysis: Semicompeting Risks as an Underutilized Framework for Cancer ResearchIna Jazić, Deborah Schrag, Daniel J Sargent, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 17, 2014
Comparative effectiveness of intensity-modulated versus 3D conformal radiation therapy among medicare patients with stage III lung cancerAileen B Chen, Ling Li, Angel Cronin, et al.
Cancer|January 3, 2014
National trends in pancreatic cancer outcomes and pattern of care among Medicare beneficiaries, 2000 through 2010Yun Wang, Deborah Schrag, Gabriel A Brooks, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Precision Oncology: Who, How, What, When, and When Not?Lee Schwartzberg, Edward S Kim, David Liu, et al.
Journal of the National Cancer Institute|August 18, 2005
Cetuximab therapy and symptomatic hypomagnesemiaDeborah Schrag, Ki Young Chung, Carlos Flombaum, et al.
Journal of the Royal Statistical Society. Series C, Applied Statistics|May 16, 2015
Bayesian Semi-parametric Analysis of Semi-competing Risks Data: Investigating Hospital Readmission after a Pancreatic Cancer DiagnosisKyu Ha Lee, Sebastien Haneuse, Deborah Schrag, et al.
JAMA Network Open|January 16, 2019
Assessment of Between-Hospital Variation in Readmission and Mortality After Cancer Surgical ProceduresSebastien Haneuse, Francesca Dominici, Sharon-Lise Normand, et al.
Medical Care|August 21, 2002
Identifying and measuring hospital characteristics using the SEER-Medicare data and other claims-based sourcesDeborah Schrag, Peter B Bach, Celia Dahlman, et al.
Cancer|August 10, 2005
The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975-1999Elena B Elkin, Clifford Hudis, Colin B Begg, et al.
Pageof 39

Showing results (51-60 of 383) with videos related to

Sort By:
Pageof 39
Journal of the American Statistical Association|March 18, 2017
Hierarchical models for semi-competing risks data with application to quality of end-of-life care for pancreatic cancerKyu Ha Lee, Francesca Dominici, Deborah Schrag, et al.
Journal of the National Cancer Institute|July 7, 2016
Beyond Composite Endpoints Analysis: Semicompeting Risks as an Underutilized Framework for Cancer ResearchIna Jazić, Deborah Schrag, Daniel J Sargent, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 17, 2014
Comparative effectiveness of intensity-modulated versus 3D conformal radiation therapy among medicare patients with stage III lung cancerAileen B Chen, Ling Li, Angel Cronin, et al.
Cancer|January 3, 2014
National trends in pancreatic cancer outcomes and pattern of care among Medicare beneficiaries, 2000 through 2010Yun Wang, Deborah Schrag, Gabriel A Brooks, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Precision Oncology: Who, How, What, When, and When Not?Lee Schwartzberg, Edward S Kim, David Liu, et al.
Journal of the National Cancer Institute|August 18, 2005
Cetuximab therapy and symptomatic hypomagnesemiaDeborah Schrag, Ki Young Chung, Carlos Flombaum, et al.
Journal of the Royal Statistical Society. Series C, Applied Statistics|May 16, 2015
Bayesian Semi-parametric Analysis of Semi-competing Risks Data: Investigating Hospital Readmission after a Pancreatic Cancer DiagnosisKyu Ha Lee, Sebastien Haneuse, Deborah Schrag, et al.
JAMA Network Open|January 16, 2019
Assessment of Between-Hospital Variation in Readmission and Mortality After Cancer Surgical ProceduresSebastien Haneuse, Francesca Dominici, Sharon-Lise Normand, et al.
Medical Care|August 21, 2002
Identifying and measuring hospital characteristics using the SEER-Medicare data and other claims-based sourcesDeborah Schrag, Peter B Bach, Celia Dahlman, et al.
Cancer|August 10, 2005
The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975-1999Elena B Elkin, Clifford Hudis, Colin B Begg, et al.
Pageof 39